Prot # 10-392: ABSORB III Randomized Controlled Trial: Clinical Evaluation of BVS Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Project: Research project

StatusActive
Effective start/end date6/25/136/25/22

Funding

  • Novella Clinical, LLC (Prot # 10-392)
  • Abbott Cardiovascular Systems, Inc. (Prot # 10-392)